China-based Hong Kong WinHealth Pharma Group Ltd’s Bo’Ao Winhealth Rare Disease Medical Center has accessed Baidu’s ERNIE Bot, the China-based internet giant’s answer to the current global phenomenon ChatGPT. This strategic move will enhance the company’s capabilities in the rare disease sector by leveraging Baidu’s leading intelligent conversation technology.
Application of ERNIE Bot in Rare Disease Area
Going forward, the entity will apply Baidu’s ERNIE Bot in the rare disease area, thus ramping up rare disease bio-services. This integration will allow WinHealth Pharma to provide patients and medical professionals with artificial intelligence (AI) whole system services in the innovative drug and device sectors around the globe. The move aims to meet multi-level use needs and create disruptive service business models.
ERNIE Bot and Future Availability
ERNIE Bot, a generative conversation product based on Baidu’s ERNIE technology, is expected to be made publicly available next month after concluding internal testing. This public release will further expand the reach and impact of AI-driven services in the healthcare sector, particularly in the area of rare diseases.-Fineline Info & Tech
